BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4303990)

  • 21. Taxonomic distribution of the antigen eliciting bactericidal antibody for Bordetella pertussis.
    Dolby JM; Ackers JP
    J Gen Microbiol; 1975 Apr; 87(2):239-44. PubMed ID: 49392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant activity of Bordetella pertussis in New Zealand mice.
    Finger H; Hof H; Elekes E; Plager L
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 147(5):437-40. PubMed ID: 4377488
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoradiographic studies on cell proliferation during splenomegaly induced by Bordetella pertussis in mice.
    Stöcker E; Finger H
    Virchows Arch B Cell Pathol; 1972; 10(3):179-83. PubMed ID: 4338202
    [No Abstract]   [Full Text] [Related]  

  • 24. The mechanism of the adjuvant effect of Bordetella pertussis: the substance responsible for the selective enhancement of IgE antibody production.
    Mota I; Perini A; Trindade VS
    Int Arch Allergy Appl Immunol; 1974; 47(3):425-32. PubMed ID: 4372184
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bordetella pertussis as an immunological adjuvant].
    Finger H; Emmerling P
    Dtsch Med Wochenschr; 1970 Jan; 95(2):89-90. PubMed ID: 4311955
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunological and histological reactions to respiratory administration of ribosomal Bordetella pertussis vaccine in mice.
    Bartlema HC; Braunius R
    Z Erkr Atmungsorgane; 1979 May; 153(2):254-60. PubMed ID: 232799
    [No Abstract]   [Full Text] [Related]  

  • 27. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
    Bomford R
    Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular site of action of various adjuvants in antibody responses to hapten-carrier conjugates.
    Hamaoka T; Katz DH
    J Immunol; 1973 Nov; 111(5):1554-63. PubMed ID: 4126779
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of Bordetella pertussis and bacterial endotoxins on the immunological reactivity of germfree mice.
    Hof H; Finger H; Karle E
    Zentralbl Bakteriol Orig A; 1975 Jun; 232(1):73-82. PubMed ID: 169652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant for IgE antibody and islet-activating protein in Bordetella pertussis.
    Mizushima Y; Mori M; Ogita T; Nakamura T
    Int Arch Allergy Appl Immunol; 1979; 58(4):426-9. PubMed ID: 220196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice.
    Ackers JP; Dolby JM
    J Gen Microbiol; 1972 Apr; 70(2):371-82. PubMed ID: 4338965
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence.
    Taub RN; Gershon RK
    J Immunol; 1972 Feb; 108(2):377-86. PubMed ID: 4114954
    [No Abstract]   [Full Text] [Related]  

  • 33. Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis.
    Taub RN; Rosett W; Adler A; Morse SI
    J Exp Med; 1972 Dec; 136(6):1581-93. PubMed ID: 4345107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
    Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathological changes in mice treated with extracts of the histamine-sensitizing factor of Bordetella pertussis.
    Lehrer SB; Nakamura RM; Tan EM
    Int Arch Allergy Appl Immunol; 1977; 54(2):129-42. PubMed ID: 193800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antigen saving function of immunological adjuvants].
    Emmerling P; Finger H; Offenhammer A
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Apr; 139(3):290-300. PubMed ID: 4321654
    [No Abstract]   [Full Text] [Related]  

  • 37. Pleurorrhea-inducing activity of the histamine-sensitizing factor of Bordetella pertussis.
    Endoh M; Fujimoto T; Nakase Y
    Microbiol Immunol; 1983; 27(11):979-84. PubMed ID: 6321914
    [No Abstract]   [Full Text] [Related]  

  • 38. Adjuvant principle of pertussis vaccine in the mouse.
    Pieroni RE; Levine L
    Nature; 1966 Sep; 211(5056):1419-20. PubMed ID: 4291099
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of Bordetella pertussis on the lymphatic tissue of mice. IV. The effect of Bordetella pertussis on the kinetics of antibody formation in mice treated with cyclophosphamide].
    Finger H; Emmerling P
    Z Immunitatsforsch Allerg Klin Immunol; 1968 Nov; 136(4):351-61. PubMed ID: 4304208
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased protein synthesis of spleen cells after injection of Bordetella pertussis into mice.
    Finger H; Stöcker E
    Beitr Pathol; 1972 Jul; 146(4):381-8. PubMed ID: 4341374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.